Percutaneous endoscopic gastrostomy in head and neck cancer patients: indications, techniques, complications and results. by Zuercher Barbara, F. et al.
MISCELLANEOUS
Percutaneous endoscopic gastrostomy in head and neck cancer
patients: indications, techniques, complications and results
Barbara F. Zuercher • Pierre Grosjean •
Philippe Monnier
Received: 12 August 2010 / Accepted: 13 October 2010 / Published online: 3 November 2010
 Springer-Verlag 2010
Abstract The aim of this study was to review our expe-
rience in percutaneous endoscopic gastrostomy (PEG)
performed in patients with cancer of the upper aerodigestive
tract. Descriptive retrospective study of 142 patients (115
males, 27 females), mean age 62.4 years (25–84 years),
with head and neck or esophageal cancer, who underwent
PEG tube insertion between January 2006 and December
2008. The studied parameters were indications, success
rate, rate and type of complications, and their management.
Percutaneous endoscopic gastrostomy was inserted before
chemoradiation therapy in 80% and during or after cancer
treatment in 20% of the patients. PEG placement was
possible in 137 patients (96%). Major complications were
observed in 9 (7%) and minor complications in 22 (17%)
of the 137 patients. Seven of the 9 patients with a major
complication needed revision surgery. The mortality
directly related to the procedure was 0.7%. Percutaneous
endoscopic gastrostomy tube insertion has a high success
rate. In patients with upper aerodigestive tract cancer,
PEG should be the first choice for enteral nutrition when
sufficient oral intake is not possible. Although apparently
easy, the procedure may occasionally lead to severe com-
plications. Therefore, a strict technique and knowledge of
clinical signs of possible complications are mandatory.
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Introduction
Introduced in 1980 by Gauderer et al. the procedure of
percutanous endoscopic gastrostomy (PEG) has been
established as the method of choice for enteral nutrition
because of its rapidity and relative ease of insertion as well
as its good tolerance and acceptance by the patients [1, 2].
Different techniques of PEG placement have been reported,
but the most widely used are either the pull method
(Ponsky-technique), where the catheter is pulled through
the upper digestive tract and out the abdominal wall [1, 3]
or the push method (Sachs-Vine-technique), where a
guidewire is placed into the stomach under endoscopic
visualization and dilated with the Seldinger technique until
the catheter is inserted through the abdomen into the
stomach [3, 4]. In patients, suffering from a cancer of the
upper aerodigestive tract, severe dysphagia leading to
impaired or impossible oral intake occurs frequently
before, during or after oncological treatment. In these sit-
uations, enteral feeding via a nasogastric tube, a PEG or
radiological gastrostomy or even an open surgical gas-
trostomy becomes necessary. As pretherapeutic assessment
of the tumor usually includes the examination of the upper
digestive tract by endoscopy, PEG placement is usually the
procedure choice in this population and is more and more
taken over by ENT specialists in these patients.
However, serious and even lethal complications of this
procedure are known to occur [5–7] and ENT specialists
should be aware of the spectrum of these complications as
well as of their early clinical manifestations. The aim of
our study was to review our experience in PEG placement
in patients with cancer of the upper aerodigestive tract,
focusing on the analysis of the rate and type of complica-
tions in order to evaluate how they could possibly be
prevented.
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Materials and methods
A retrospective study of 142 consecutive patients with a
cancer of the upper aero-digestive tract who underwent
PEG tube placement was conducted in the ENT Depart-
ment of the University Hospital (CHUV) of Lausanne,
Switzerland between January 2006 and December 2008.
Approval from Institutional Review Board (IRB) was
granted. The procedure was performed exclusively by ENT
specialists.
The inclusion criteria were a history of upper aero-
digestive tract cancer and a follow-up of at least 3 months
after the procedure.
The collected demographic data included: age and sex
of patient, site and stage of the tumor. The indication for
PEG placement, the success or failure of PEG insertion, the
number of puncture for successful placement, the use of
prophylactic antibiotics, the number and type of compli-
cations and their management were also recorded. The
relative risk of complications related to multiple punctures
and to the lack of prophylactic antibiotics was calculated.
Complications were divided into major and minor ones.
Major complication included either the need for revision
surgery, the necessity of blood transfusion, or death of the
patient within 30 days after the procedure. A complication
was classified as minor if it could be managed by simple
observation, local care at bedside or replacement of the
gastrostomy tube.
Technique of PEG insertion
The standard pull method (Ponsky-technique) [3] was used
in all patients. All procedures were performed by two
surgeons, and under general anesthesia. Gastroscopy is
performed with a standard videogastroscope. The stomach
is inflated, so that its anterior wall will come in contact
with the abdominal wall. The site of puncture is in the left
epigastrium, at least 2 cm below the costal arch and usually
about 2 cm paramedian to the left side. Its accurate loca-
tion is determined by the point of maximal transillumina-
tion and maximal digital imprint on the anterior gastric
wall as visualized by the endoscope. After the abdomen has
been prepared and dressed, a first puncture with a fine
needle (20G) is performed under continued aspiration until
the needle tip is visualized in the stomach. The observation
of air bubble in the syringe before seeing the needle tip in
the stomach should alert on the possibility of bowel
puncture. During withdrawal of the needle, local anesthetic
is injected in the area around the puncture side. The pres-
sure of the digital imprint is always maintained until the
large-bore needle (trocar) is inserted into the gastric lumen
under endoscopic control. Then, a pilot thread is placed
through the trocar into the stomach and grasped by a biopsy
forceps. In a single unit, the endoscope and the guidewire
are withdrawn through the mouth. The end of the tube is
fixed to the guidewire and pulled gently back down into the
stomach and through the abdominal wall. If needed, a small
cutaneous incision can be performed to ease the passage of
the tube through the skin. The tube is fixed by an external
bumper under adequate tension to avoid dislodgement of
the gastric wall from the abdominal wall. A mark on the
tube at the level of the skin is performed with a water-
resistant pen to identify any postoperative dislodgement of
the tube. The external end is covered by a sterile trans-
parent dressing. A final control by endoscopy is performed
to confirm the accurate position of the PEG-bumper and to
rule out excessive bleeding or gastric perforation.
Postoperative care
Oral realimentation can be started 6 h after surgery with
first liquid diet followed by normal diet after 13 h. Enteral
realimentation by the PEG includes 500 cc of sterile
saline solution between the 7th and the 13th hour post-
operatively, followed by progressive enteral nutrition if
well supported.
At day 6 postoperatively, the dressing is changed for the
first time and the tube is mobilized vertically and by
rotation to avoid impaction of the internal bumper into the
gastric wall. Repositioning of the tube is made by traction
on the tube until the mark performed during surgery
appears at the skin level or according to the graduation on
the tube. During the next 10 days, the sterile dressing is
changed daily. After the 16th postoperative day, no
dressing is necessary unless leakage is present, but local
care with soap and daily mobilization of the PEG remains
necessary.
Results
Our study included 142 patients. There were 115 males and
27 females with an average age of 62.4 years (25–82 years).
None of these patients had preoperative contraindication to
PEG placement such as coagulopathy, previous gastrec-
tomy, ascites or morbid obesity.
Indications for PEG placement
In 113 of the 142 patients (79.6%), PEG tube placement
was indicated before primary (99 patients) or adjuvant (14
patients) chemoradiation therapy. In the remaining 29
patients (20.4%), PEG was inserted because of long-lasting
dysphagia, secondary to previous surgery (16 cases),
extended tumor (11 cases) or to benign esophageal stenosis
(2 cases).
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The majority of the patients (92%) presented with an
advanced stage of cancer (stage III or IV) in which 76% of
the patients were localized in the oral cavity or the pharynx
(Table 1). Eight patients underwent palliative oncologic
treatment (5.6%).
Success
Percutaneous endoscopic gastrostomy tube insertion was
possible in 137 of the 142 patients (96%). In five patients,
the placement of PEG was not possible for the following
reasons: lack of transillumination in three cases and
impossibility to endoscopically reach the stomach because
of a tight esophageal stenosis in two cases, respectively. In
126 patients, PEG was inserted after a single abdominal
puncture, whereas 11 patients required two or more punc-
tures for a successful insertion of the tube.
Complications
Nine patients (7%) presented with a major complication
(Table 2), requiring a surgical revision by laparoscopy or
laparotomy in 7 of them. Despite surgical treatment, 1 of
these 7 patients, suffering from a large iatrogenic gastric
perforation supposed to be related to excessive inflation
during PEG insertion, died. The mortality related to the
procedure was, therefore, 0.7% (1/137). Another patient
with preoperative gastric perforation was successfully
treated by surgery. In the remaining 3, surgical revision
was indicated because of a pneumoperitoneum and peri-
tonitis that occurred after secondary dislodgement of the
PEG tube (Fig. 1). Postoperative course was uneventful in
these three patients.
One patient, with immediate uneventful postoperative
course presented a fecal discharge around the PEG tube
2 weeks after PEG insertion. A CT-scan of the abdomen
showing interposition of the transverse colon between the
abdominal wall and the stomach was diagnostic for a
gastrocolocutaneous fistula (Fig. 2). Surgical treatment
with removal of the PEG and segmental colon resection led
to complete recovery.
One patient presented with mediastinitis and pleural
empyema after esophageal perforation following dilatation
of a tumoral obstruction at the same time as PEG insertion.
The patient was ineligible for major surgery but recovery
was observed after prolonged intravenous antibiotic
treatment.
Two patients with uncomplicated PEG insertion pre-
sented a major complication during the course of chemo-
therapy. One patient presented with severe abdominal wall
bleeding secondary to chemotherapy-induced thrombocy-
topenia. Another patient with post-chemotherapy agranu-
locytosis developed abdominal wall necrosis and abscess
that required surgical management.
Table 1 Tumor location and TNM stage
Location Stage
I II III IV
Oral cavity 0 3 15 20
Oro-hypopharynx 0 8 27 46
Larynx 1 2 1 5
Rhinopharynx 0 0 0 5
Esophagus 0 0 5 1
Unknown primary 0 0 1 2
Total 1 13 49 79
Table 2 Complications related to PEG placement (N = 137 patients)
Major complications N = 9 (7%)
Secondary displacement of the tube with
pneumoperitoneum or peritonitis
3 (2.2%)
Gastric perforation 2 (1.5%)
Esophageal perforation with mediastinitis 1 (0.7%)
Transcolic puncture 1 (0.7%)
Abscess/necrosis of the abdominal wall 1 (0.7%)
Abdominal wall bleeding 1 (0.7%)
Minor complications N = 22 (17%)
Severe abdominal pain 9 (6.6%)
Local infection 8 (5.8%)
Minor bleeding 3 (2.2%)
Secondary dislocation of the tube
treated conservatively
2 (1.5%)
Fig. 1 Dislodgement of the PEG tube (arrow) with pneumoperito-
neum (*) and subcutaneous emphysema (v)
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Twenty-two patients (17%) presented with a minor com-
plications (Table 2). Nine patients complained of sudden
onset of severe abdominal pain after mobilization, meal or the
first dressing. The clinical evolution was favorable and enteral
or oral feeding could be resumed after 1–2 days of observa-
tion. In two patients, who had similar symptoms, secondary
dislocation of the tube was discovered by conventional radi-
ography or CT-Scan. The treatment consisted of immediate
repositioning of the tube with rapid clinical resolution of
symptoms. We noted eight patients with a local infection,
which could be treated with dressings or oral antibiotics.
Prophylactic antibiotics
Prophylactic antibiotics, mainly amoxicillin and clavulanic
acid (94.7%), followed by clarithromycin (2.1%) and ce-
furoxime (2.1%), were given in 95 patients. No prophy-
lactic antibiotics were given in 41 patients. We could not
get any information about intraoperative antibiotic pro-
phylaxis for one patient.
Comparing the rate of complication in patients that
received prophylactic antibiotics with those who did not,
the relative risk of suffering a complication without anti-
biotics was 1.9 and 2.8 for major and minor complication,
respectively.
Similarly, the relative risk of suffering from a major
complication, when more than one puncture was required
for PEG insertion, was 3.3.
Discussion
Percutaneous endoscopic gastrostomy is a well-established
method for enteral feeding that may be indicated in a wide
range of swallowing disorders: neurological disease,
tumoral or long-lasting postoperative dysphagia [7]. In
oncology, enteral alimentation by PEG is often used for
patients with cancer of the upper aero-digestive tract, either
during chemoradiation therapy or for prolonged post-
treatment dysphagia.
In examining the predictive factors for the need of
prolonged enteral feeding in patients with upper aerodi-
gestive tract cancer, Gardine et al. [8] found that advanced
cancer stage (mainly stage IV), primary pharyngeal tumors,
combined treatment of surgery and radiotherapy and pre-
operative weight loss of more than 10 lb may serve as
indications for PEG insertion. In our group of head and
neck cancer patients, the main indications for PEG place-
ment were adjuvant or exclusive chemo-irradiation
(79.6%), oral or pharyngeal tumor location (76%), and
advanced disease (stage III or IV) (92%). We proposed
PEG placement as early as possible before the start of
chemoradiation therapy and tried to avoid PEG insertion
when the patient was at risk of developing altered blood
counts secondary to chemotherapy. As a matter of fact, two
patients in our series presented a major complication
(bleeding and abdominal wall abscess and necrosis) related
to chemotherapy-induced thrombopenia and agranulocy-
tosis, respectively. Both of them had PEG placement just
before the start of chemotherapy.
No patient in our series had PEG placement before
tumor resection unless adjuvant chemoradiation was plan-
ned after surgery. Raynor et al. [9] showed an increased
complication rate in patients who underwent PEG place-
ment preoperatively and proposed the ideal time of PEG
placement either during tumor resection or in the postop-
erative period, but not preoperatively. It should be, how-
ever, mentioned, that dysphagic patients with severe
weight loss before diagnostic and management of head and
neck cancer may benefit from preoperative enteral nutrition
in order to decrease the rate of surgical complications [10].
In this group of patient and especially if prolonged oral
feeding is likely to be impaired, PEG insertion seems to be
the method of choice and can be inserted in the setting of
pretherapy panendoscopy.
Prophylactic antibiotics
Different studies examining the benefit of antibiotic pro-
phylaxis for PEG placement showed decreased incidence
of wound infections when antibiotics were administered
[11, 12]. Penicillin-based prophylaxis showed better results
than cephalosporin prophylaxis [11, 12]. In our series,
Fig. 2 Gastrocolocutaneous fistula with transcolic passage of the
PEG tube (arrow)
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prophylactic antibiotic therapy was given in 95 PEG
placements. In accordance with the previous reports from
the literature, we noticed an increased risk of 1.9 and 2.8
for major and minor complication, respectively, in patients
without prophylactic antibiotics.
Complications
The technique of PEG insertion is relatively simple and the
success rate in our series was 96%. The reported success
rate in the literature varies between 95 and 100% [13].
However, 7% of the patients in our series presented with
major complications which correlates well with the rate
reported in the literature (1.1–17%) [5, 7, 13, 14]. Minor
complication rates of 17% in our series also concurred with
reported rates ranging from 8.3 to 65% [6, 15, 16]. In our
series, the procedure-related mortality was 0.7% and is in
the range of those reported in the literature (1–2%) [14].
One patient presented with a gastrocolocutaneous fistula
due to transcolic puncture (Fig. 2). In the literature, the
reported incidence of this severe complication may be as
high as 2–3% [5]. Theoretically, the risk of this compli-
cation should be limited if
1. sufficient inflation of the stomach is performed, thus
allowing close apposition of the stomach to the
abdominal wall by pushing the large bowel and liver
away.
2. the transillumination of the abdominal wall (Fig. 3) as
well as the imprint of the finger (Fig. 4) are clearly
visualized from outside and inside, respectively, and
maintained until the trocar has been correctly inserted.
3. the first puncture is performed with a fine needle (20G)
under continuous aspiration. If air is aspirated before
endoscopic visualization of the needle in the stomach,
a colic puncture must be suspected and the puncture
has to be repeated in another direction before entering
the trocar.
Whereas sufficient inflation of the stomach is likely to
reduce the risk of transcolic puncture, it should be men-
tioned that overinflation may on the contrary increase this
risk as described by Patwardhan [17]. In his series of 12
cases of gastrocolocutaneous fistula, the author noted that
the puncture always occurred in the posterior wall of the
stomach. This was also observed in our case (Fig. 2). It is
hypothesized that excessive inflation of the stomach before
PEG insertion, may cause an anterior rotation of the greater
curvature including the gastrocolic omentum and the
transverse colon which, therefore, lies between the stomach
and the abdominal wall [18].
Friedmann et al. [19] reported 28 cases of PEG mis-
placement into the colon. Most patients (17/28) became
symptomatic after blind tube replacement with sudden
onset of severe watery diarrhea soon after feeding. Eleven
of 28 patients presented fecal discharge in or around the
tube between 3 and 75 days after PEG placement. Our
patient also remained asymptomatic for 2 weeks before
presenting with fecal discharge around the tube. It is
important to keep in mind that this rare complication may
become apparent only several weeks or months after PEG
placement or when the tube is removed.
While overinflation may increase the risk of transcolic
PEG insertion, it may also lead to gastric rupture as
observed in one of our patient.
One patient in our series with synchronous head and
neck and esophageal cancer presented with a perforation of
the esophagus following dilatation of his tumoral stricture
which remained undetected during the surgical procedure.
He developed a mediastinitis which required prolonged
antibiotic treatment alone as the patient was not eligible for
major surgery. Therefore, in tumoral stricture of the
esophagus, radiologic percutaneous gastrostomy, which
generally does not require dilatation, should be consideredFig. 3 Transillumination in the left epigastric region (arrow)
Fig. 4 Endoscopic view of the digital imprint (arrow)
Eur Arch Otorhinolaryngol (2011) 268:623–629 627
123
the procedure of choice, unless the treatment is only pal-
liative. In this case, PEG insertion can be combined with
esophageal stent placement.
Inadvertent removal of PEG tube is a problem which
occurs especially in disoriented patients, with an incidence
of 1.6–4.4% [7, 20, 21]. We had no case of complete tube
removal but recorded five cases of partial PEG dislodge-
ment. In two patients, partial tube dislodgement was rec-
ognized early and immediate repositioning of the PEG tube
by simple traction was followed by uncomplicated clinical
course. In the other three patients, partial dislodgement of
the PEG tube was only recognized after the patient
developed acute abdominal pain with peritonitis or pneu-
moperitoneum. All three patients required surgical treat-
ment. It should be noted that not all patients presenting
acute abdominal pain after PEG insertion suffer from PEG
dislodgement as illustrated by our group of nine patients
with severe abdominal pain in whom no evidence of direct
or indirect sign of PEG displacement could be demon-
strated radiologically. Nevertheless, PEG displacement
should always be excluded in such patients, especially if
symptoms occur shortly after PEG mobilization or after the
first enteral feeding. In this regard, marking the PEG tube
at the level of the skin at the time of insertion when the
correct position of the device can be assessed endoscopi-
cally provides an easy and reliable landmark of correct tube
positioning in the postoperative period.
Although stomal tumoral seeding with development of
abdominal wall metastases has been occasionally described
in head and neck cancer patients undergoing PEG insertion
by the pull technique, this seems to occur very rarely.
Schrag [7] reported an incidence of less than 1% and
Adelson [22] could only find 22 cases in a Medline search
performed in 2004. Some authors recommend avoiding
PEG insertion in patients with oropharyngeal or esophageal
cancer [23]. Other authors proposed to use laparoscopy or
open gastrostomy, or the push instead of the pull technique,
to avoid tumor cell seeding [22]. No such complication was
observed in our series and thus we presume that head and
neck cancer should not be considered a contraindication to
PEG insertion.
Finally, and although this was not the subject of our
present study, it should be born in mind that enteral feeding
with a PEG, although more invasive, presents many nutri-
tional advantages compared to feeding with a nasogastric
tube. In particular, several studies have demonstrated that in
patients with head and neck cancer treated by radiation
therapy, nutritional support via the PEG resulted in less
weight loss, fewer hospitalizations for treatment-related
complications, fewer interruptions of radiation, less treat-
ment failures, and lower mortality [24] as compared to ent-
eral feeding via nasogastric tube. In addition, the advantage
of PEG feeding with regard to comfort and esthetic aspects
are obvious [25, 26].
Conclusion
Percutaneous endoscopic gastrostomy placement has
become the feeding modality of choice for patients with
upper aerodigestive cancer who require mid- or long-term
enteral nutrition. The surgical procedure is relatively sim-
ple but major complications may occur. A sound knowl-
edge of these complications and especially of their early
symptoms is mandatory. In addition, strict adherence to a
rigorous surgical technique is essential to reduce the inci-
dence of complications especially in a group of patients
with frequent comorbidities.
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